Enovix (NASDAQ:ENVX) Trading Down 8.3% – Here’s Why

by · The Markets Daily

Shares of Enovix Co. (NASDAQ:ENVX – Get Free Report) fell 8.3% on Wednesday . The company traded as low as $13.06 and last traded at $13.14. 4,158,394 shares were traded during mid-day trading, a decline of 57% from the average session volume of 9,569,026 shares. The stock had previously closed at $14.33.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on ENVX shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $30.00 target price on shares of Enovix in a research report on Wednesday, October 30th. JPMorgan Chase & Co. dropped their target price on Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Janney Montgomery Scott cut Enovix from a “buy” rating to a “neutral” rating and set a $10.00 target price on the stock. in a research report on Thursday, October 31st. Finally, Benchmark reissued a “buy” rating and issued a $25.00 target price on shares of Enovix in a research report on Wednesday, October 30th. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Enovix presently has a consensus rating of “Moderate Buy” and an average price target of $20.50.

Get Our Latest Stock Report on ENVX

Enovix Price Performance

The firm has a 50 day moving average price of $9.87 and a 200 day moving average price of $11.15. The company has a quick ratio of 3.61, a current ratio of 3.77 and a debt-to-equity ratio of 0.99. The stock has a market cap of $2.03 billion, a P/E ratio of -7.07 and a beta of 1.86.

Enovix (NASDAQ:ENVX – Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.20) by $0.03. The firm had revenue of $4.30 million for the quarter, compared to the consensus estimate of $4.11 million. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. During the same quarter last year, the company earned ($0.27) earnings per share. On average, analysts forecast that Enovix Co. will post -1.17 EPS for the current fiscal year.

Insider Activity at Enovix

In other Enovix news, insider Arthi Chakravarthy sold 35,000 shares of Enovix stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $13.00, for a total value of $455,000.00. Following the sale, the insider now owns 343,305 shares of the company’s stock, valued at $4,462,965. The trade was a 9.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Betsy S. Atkins sold 75,000 shares of Enovix stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total value of $729,750.00. Following the completion of the sale, the director now directly owns 99,497 shares in the company, valued at approximately $968,105.81. The trade was a 42.98 % decrease in their position. The disclosure for this sale can be found here. 15.70% of the stock is owned by corporate insiders.

Institutional Trading of Enovix

Large investors have recently added to or reduced their stakes in the company. Strategic Investment Solutions Inc. IL purchased a new position in shares of Enovix in the 2nd quarter worth approximately $39,000. Prospera Private Wealth LLC purchased a new position in shares of Enovix in the 3rd quarter worth approximately $27,000. Headlands Technologies LLC purchased a new position in shares of Enovix in the 2nd quarter worth approximately $97,000. Voisard Asset Management Group Inc. boosted its holdings in shares of Enovix by 40.0% in the 3rd quarter. Voisard Asset Management Group Inc. now owns 7,000 shares of the company’s stock worth $65,000 after purchasing an additional 2,000 shares during the period. Finally, Quest Partners LLC boosted its holdings in shares of Enovix by 318.5% in the 3rd quarter. Quest Partners LLC now owns 8,270 shares of the company’s stock worth $77,000 after purchasing an additional 6,294 shares during the period. Institutional investors own 50.92% of the company’s stock.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Read More